{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:12:33Z","timestamp":1790845953857,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006129","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/00100\/2013"],"award-info":[{"award-number":["UID\/QUI\/00100\/2013"]}],"id":[{"id":"10.13039\/100006129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejmech.2018.02.023","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T12:34:48Z","timestamp":1518438888000},"page":"255-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease"],"prefix":"10.1016","volume":"148","author":[{"given":"Asha","family":"Hiremathad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangappa S.","family":"Keri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Raquel","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-9368","authenticated-orcid":false,"given":"M. Am\u00e9lia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.02.023_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"2015 Alzheimer's disease facts and figures","volume":"11","author":"Alzheimer\u2019s Association","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ejmech.2018.02.023_bib2","author":"World Health Organization"},{"key":"10.1016\/j.ejmech.2018.02.023_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Henry","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.02.023_bib4","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/cr300009x","article-title":"Bioinorganic chemistry of Alzheimer's disease","volume":"112","author":"Kepp","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.02.023_bib5","first-page":"187","article-title":"Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance","volume":"6","author":"Marr","year":"2014","journal-title":"Aging Neurosci"},{"key":"10.1016\/j.ejmech.2018.02.023_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrn2967","article-title":"Amyloid-\u03b2 and tau\u2013a toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2018.02.023_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005072-199808000-00001","article-title":"Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited","volume":"57","author":"Ladner","year":"1998","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2018.02.023_bib8","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0047-6374(01)00309-8","article-title":"Acetylcholinesterase in Alzheimer's disease","volume":"122","author":"Talesa","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejmech.2018.02.023_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer's disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed. Rep"},{"key":"10.1016\/j.ejmech.2018.02.023_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nurt.2008.05.001","article-title":"Therapeutics for Alzheimer's disease based on the metal hypothesis","volume":"5","author":"Bush","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2018.02.023_bib11","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.ccr.2012.03.008","article-title":"The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases","volume":"256","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2012","journal-title":"C.\u00a0Orvig, Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.02.023_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2016.04.013","article-title":"Recent progress in multifunctional metal chelators as potential drugs for Alzheimer's disease","volume":"327\u2013328","author":"Santos","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.02.023_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jalz.2010.03.016","article-title":"Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease","volume":"7","author":"Small","year":"2011","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ejmech.2018.02.023_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.ejmech.2018.02.023_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease","volume":"33","author":"Leon","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2018.02.023_bib17","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ejmech.2017.08.021","article-title":"A\u00a0novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease","volume":"139","author":"Palanimuthu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib18","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.4155\/fmc-2016-0103","article-title":"Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy","volume":"8","author":"Santos","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib19","series-title":"Design of Hybrid Molecules for Drug Development","author":"Decker","year":"2017"},{"key":"10.1016\/j.ejmech.2018.02.023_bib20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/106002809402800612","article-title":"Tacrine: first drug approved for Alzheimer's disease","volume":"28","author":"Crismon","year":"1994","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejmech.2018.02.023_bib21","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1021\/ar500152x","article-title":"The ongoing search for small molecules to study metal-associated amyloid-\u03b2 species in Alzheimer's disease","volume":"47","author":"Savelieff","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.02.023_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2010.01.042","article-title":"Acetylcholinesterase: from 3D structure to function","volume":"187","author":"Dvir","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2018.02.023_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ejmech.2016.06.025","volume":"121","author":"Ceshi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cbi.2010.02.013","volume":"187","author":"Campos","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2018.02.023_bib25","author":"PDB"},{"key":"10.1016\/j.ejmech.2018.02.023_bib26","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1021\/jm060164b","volume":"49","author":"Rydberg","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/jo01174a009","article-title":"Attempts to find new antimalarials; studies in the acridine series; dialkylaminoalkylamines derived from 9-chloro-1,2,3,4-tetrahydroacridine","volume":"11","author":"Sargent","year":"1946","journal-title":"Org. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib28","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0040-4039(00)00036-8","article-title":"A\u00a0facile synthesis of bis-tacrine isosteres","volume":"41","author":"Hu","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.02.023_bib29","doi-asserted-by":"crossref","first-page":"S1788","DOI":"10.1016\/j.arabjc.2013.07.003","article-title":"Synthesis and biological evaluation of 2-(phenyl)-3H-benzo[d]imidazole-5-carboxylic acids and its methyl esters as potent anti-breast cancer agents","volume":"10","author":"Karthikeyan","year":"2017","journal-title":"Arabian J. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib30","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1039\/c3dt50406a","article-title":"Multifunctional iron-chelators with protective roles against neurodegenerative diseases","volume":"42","author":"Nunes","year":"2013","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2018.02.023_bib31","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/cbic.200700427","article-title":"Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action","volume":"8","author":"Bartolini","year":"2007","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2018.02.023_bib32","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1016\/j.bmcl.2012.08.036","article-title":"Design, synthesis and pharmacological evaluation of novel tacrine\u2013caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease","volume":"22","author":"Chao","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.023_bib33","unstructured":"S. Chaves, A. Hiremathad, D. Tom\u00e1s, R.S. Keri, L. Piemontese, M.A. Santos, unpublished results."},{"key":"10.1016\/j.ejmech.2018.02.023_bib34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1039\/B813398K","article-title":"Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-\u03b2 peptide","author":"Faller","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2018.02.023_bib35","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1039\/C6DT02308H","article-title":"How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study","volume":"45","author":"Conte-Daban","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2018.02.023_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.foodchem.2003.09.013","article-title":"Antimicrobial and antioxidant activities of the essential oil and various extracts of Salvia tomentosa Miller (Lamiaceae)","volume":"90","author":"Tepe","year":"2005","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-12-394816-8.00003-9","article-title":"Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention","volume":"64","author":"Silva","year":"2012","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.02.023_bib38","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1093\/hmg\/ddt247","article-title":"Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines","volume":"22","author":"Silva","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2018.02.023_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2018.02.023_bib40","unstructured":"QikProp, version 2.5, Schr\u00f6dinger, LLC, New York, NY, 2005."},{"key":"10.1016\/j.ejmech.2018.02.023_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2018.02.023_bib42","unstructured":"Maestro, version 9.3. Schr\u00f6dinger Inc.: Portland, OR, 2012."},{"key":"10.1016\/j.ejmech.2018.02.023_bib43","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/jcc.1080","article-title":"New energy terms for reduced protein models implemented in an off-lattice force field","volume":"22","author":"Hassinen","year":"2001","journal-title":"Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib44","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcc.540100804","article-title":"Validation of the general purpose tripos 5.2 force field","volume":"10","author":"Clark","year":"2004","journal-title":"N.\u00a0J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2018.02.023_bib46","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1039\/C5MD00236B","article-title":"Design, synthesis and bioevaluation of tacrine hybrids with cinnamate and cinnamylidene acetate derivatives as potential anti-Alzheimer drugs","volume":"6","author":"Quintanova","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2018.02.023_bib47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/14756366.2010.529806","article-title":"Bifunctional phenolic-choline conjugates as anti-oxidants and acetylcholinesterase inhibitors","volume":"26","author":"Sebest\u00edk","year":"2011","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.023_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Meth."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:44:21Z","timestamp":1759326261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341830151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":48,"alternative-id":["S022352341830151X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.023","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}